MedTrace Logo

Minimally Invasive Rheumatic Mitral Valve Surgery

NCT05270590 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2022-03-08

No results posted yet for this study

Summary

Early outcome of minimally invasive rheumatic mitral valve surgery through periareolar versus submamary approach

Conditions

  • Rheumatic Mitral Valve Disease

Interventions

PROCEDURE

minimally invasive rheumatic mitral valve surgery

First, venous and arterial access was established. Incision establishment: A 4 to 6 cm incision was opened in the chest anterolaterally to the right of the fourth intercostal space (in submamarry vs. peri areolar approach ). The thoracoscope was inserted. Bypass started, and Chitwood occlusion forceps were inserted to block the ascending aorta, purse-string suturing of the cardioplegia cannula and antegradecardioplegia fluid was performed, the interatrial groove was freed, the left atrial incision was made. Removal of the damaged mitral valve mostly by endoscopic surgical instruments (not usually there is a chance for repair), and the mitral valve was sutured intermittently. After examination of the valve location and the opening and closing performance of the valve leaf, the left atrial incision was sutured continuously by prolene 4/0. Weaning from bypass start

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Anwar A Atia, MD in cardiothoracic surgery · Professor of cardiothoracic surgery

  • Ahmed N Malik, MD in cardiothoracic surgery · Professor of cardiothoracic surgery

Eligibility

Min Age
10 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2025-01-01
Completion
2026-01-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05270590 on ClinicalTrials.gov